I. Maremmani

发表

M. Dernovsek, M. Lovrečič, Imenovanje mentorja, 2007 .

I. Maremmani, P. Castrogiovanni, O. Zolesi, 1995 .

Effects of phototherapy on non-seasonal unipolar and bipolar depressive spectrum disorders.

C. Pollak, I. Maremmani, J. Deltito, 1991, Journal of affective disorders.

Treating alcohol dependence with an abuse and misuse deterrent formulation of sodium oxybate: Results of a randomised, double-blind, placebo-controlled study

R. Spanagel, A. Goudriaan, I. Maremmani, 2021, European Neuropsychopharmacology.

Can Ropinirole Modulate Reinforcing Subjective Effects of Cocaine in Humans?

I. Maremmani, L. Dell’Osso, A. G. Maremmani, 2011, Front. Psychiatry.

Variations in platelets 3H-imipramine binding during two different periods of the year.

I. Maremmani, G. Cassano, D. Marazziti, 1989, Chronobiology international.

Does Dual Diagnosis Affect Violence and Moderate/Superficial Self-harm in Heroin Addiction at Treatment Entry?

I. Maremmani, L. Dell’Osso, A. G. Maremmani, 2014, Journal of addiction medicine.

Putative clinical subtypes of social phobia: a factor-analytical study

H. Akiskal, G. Perugi, I. Maremmani, 2001 .

Putative clinical subtypes of social phobia:a factor‐analytical study

H. Akiskal, G. Perugi, I. Maremmani, 2001, Acta psychiatrica Scandinavica.

Opioid Treatment and Long QT Syndrome (LQTS): a Critical Review of the Literature

I. Maremmani, L. Dell’Osso, M. Pacini, 2009 .

ECG screening for preventing long QTc-related cardiac morbidity/mortality in methadone treated opioid addict.

I. Maremmani, M. Pacini, P. Pani, 2011 .

Mood Stabilizers in the Treatment of Substance Use Disorders

H. Akiskal, G. Perugi, I. Maremmani, 2010, CNS Spectrums.

Sodium oxybate for the maintenance of abstinence in alcohol-dependent patients: An international, multicenter, randomized, double-blind, placebo-controlled trial

W. van den Brink, D. Nutt, J. Rehm, 2022, Journal of psychopharmacology.

What we have learned from the Methadone Maintenance Treatment of Dual Disorder Heroin Use Disorder patients

I. Maremmani, A. G. Maremmani, M. Pacini, 2019, International journal of environmental research and public health.

Differential changes in areas of social adjustment from depressive episodes through recovery.

H. Akiskal, G. Perugi, I. Maremmani, 1988, Journal of affective disorders.

Clonazepam as Agonist Substitution Treatment for Benzodiazepine Dependence: A Case Report

I. Maremmani, L. Dell’Osso, A. G. Maremmani, 2013, Case reports in psychiatry.

Sodium oxybate plus nalmefene for the treatment of alcohol use disorder: A case series

I. Maremmani, G. Addolorato, G. Zoli, 2016, Journal of psychopharmacology.

Correlations Between Awareness of Illness (Insight) and History of Addiction in Heroin-Addicted Patients

G. Perugi, I. Maremmani, J. Deltito, 2012, Front. Psychiatry.

Discriminant and convergent validity of TEMPS-A[P]. Correlation with Occupational Personality Questionnaire (OPQ32) during a stressful situation.

H. Akiskal, I. Maremmani, L. Dell’Osso, 2013, Journal of affective disorders.

Discriminant and convergent validity of TEMPS-A[P] correlation with MMPI and the emotional-affective state following a stressful situation.

H. Akiskal, D. Popovic, G. Perugi, 2011, Journal of affective disorders.

Addictive disorders, bipolar spectrum and the impulsive link: The psychopathology of a self-regenerating pathway.

G. Perugi, I. Maremmani, M. Pacini, 2005 .

Psychopathology of addiction: May a SCL-90-based five dimensions structure be applied irrespectively of the involved drug?

L. Amato, M. Davoli, I. Maremmani, 2016, Annals of General Psychiatry.

The impact of psychopathological subtypes on retention rate of patients with substance use disorder entering residential therapeutic community treatment

L. Amato, M. Davoli, I. Maremmani, 2016, Annals of General Psychiatry.

Chronology of illness in dual diagnosis heroin addicts: The role of mood disorders.

H. Akiskal, I. Maremmani, L. Dell’Osso, 2015, Journal of affective disorders.

Can the migration process influence the clinical expression of heroin use disorder in migrants to Italy?

I. Maremmani, A. G. Maremmani, A. Lupi, 2020, CNS Spectrums.

TEMPS-I: delineating the most discriminant traits of the cyclothymic, depressive, hyperthymic and irritable temperaments in a nonpatient population.

H. Akiskal, I. Maremmani, G. Placidi, 1998, Journal of affective disorders.

Interaction between the serotonin and dopamine systems in humans: preliminary findings

I. Maremmani, D. Marazziti, P. Castrogiovanni, 1989, Brain Research.

High-affinity 3H-imipramine binding sites: A possible state-dependent marker for major depression

G. Perugi, I. Maremmani, J. Deltito, 1988, Psychiatry Research.

Baseline severity and the prediction of placebo response in clinical trials for alcohol dependence: A meta‐regression analysis to develop an enrichment strategy

W. van den Brink, D. Nutt, J. Rehm, 2021, Alcoholism, clinical and experimental research.

Episodic course in obsessive-compulsive disorder

H. Akiskal, G. Perugi, I. Maremmani, 1998, European Archives of Psychiatry and Clinical Neuroscience.

Cocaine abuse and the bipolar spectrum in 1090 heroin addicts: clinical observations and a proposed pathophysiologic model.

H. Akiskal, G. Perugi, I. Maremmani, 2008, Journal of affective disorders.

QTc Interval Prolongation in Patients on Long-Term Methadone Maintenance Therapy

G. Perugi, M. Lovrečič, I. Maremmani, 2004, European Addiction Research.

What Have We Learned From the Agonist Opioid Treatment of Dual Disorder Heroin Addicts?

I. Maremmani, M. Pacini, 2017 .

Who are Resistant Patients? Quality of Treatment and Disease Control

I. Maremmani, L. Dell’Osso, A. G. Maremmani, 2014 .

Predictors for non-relapsing status in methadone-maintained heroin addicts. A long-term perspective study

G. Perugi, I. Maremmani, J. Deltito, 2008 .

Is mood-incongruent manic psychosis a distinct subtype?

H. Akiskal, G. Perugi, I. Maremmani, 2001, European Archives of Psychiatry and Clinical Neuroscience.

Gamma Hydroxybutyric Acid (GHB) for the Treatment of Alcohol Dependence: A Review

I. Maremmani, G. Zoli, M. Bernardi, 2009, International journal of environmental research and public health.

Joint statement on dual disorders: addiction and other mental disorders

R. Baler, M. Medina-Mora, J. Martínez-Raga, 2017 .

Heroin Add 10(2).indb

G. Perugi, I. Maremmani, H. Alho, 2008 .

TEMPS-A[p] temperament profile related to professional choice: A study in 1548 applicants to become a cadet officer in the Italian air force.

H. Akiskal, I. Maremmani, L. Dell’Osso, 2010, Journal of affective disorders.

Lifetime mood symptoms and adult separation anxiety in patients with complicated grief and/or post-traumatic stress disorder: A preliminary report

M. Shear, G. Perugi, I. Maremmani, 2012, Psychiatry Research.

Substance Use Disorder in Adult-Attention Deficit Hyperactive Disorder Patients: Patterns of Use and Related Clinical Features

G. Perugi, I. Maremmani, Marco Carli, 2020, International journal of environmental research and public health.

The importance of separation anxiety in the differentiation of panic disorder from agoraphobia.

G. Perugi, I. Maremmani, J. Deltito, 1986, Psychiatric developments.

Alcohol and Cocaine Use and Abuse Among Opioid Addicts Engaged in a Methadone Maintenance Treatment Program

G. Perugi, M. Lovrečič, I. Maremmani, 2007, Journal of addictive diseases.

Comparison between Heroin and Heroin–Cocaine Polyabusers

G. Perugi, I. Maremmani, F. Fornai, 2006, Annals of the New York Academy of Sciences.

Harm Reduction as “Continuum Care” in Alcohol Abuse Disorder

A. Rossi, I. Maremmani, G. Turchetti, 2015, International journal of environmental research and public health.

Former Heroin-Dependent Alcohol Use Disorder Patients. Prevalence, Addiction History and Clinical Features.

I. Maremmani, A. G. Maremmani, M. Pacini, 2015, Alcohol and alcoholism.

Non-Medical Use of Novel Synthetic Opioids: A New Challenge to Public Health

M. Lovrečič, I. Maremmani, A. G. Maremmani, 2019, International journal of environmental research and public health.

Time-Course of Buprenorphine Dose Increase in a Maintenance Program for Heroin Addicts: Retention in Treatment and Clinical Meaning

I. Maremmani, M. Pacini, Sonia Lubrano, 2016 .

Buprenorphine-based regimens and methadone for the medical management of opioid dependence: selecting the appropriate drug for treatment.

I. Maremmani, G. Gerra, 2010, The American journal on addictions.

Buprenorphine as a psychoactive drug

I. Maremmani, V. Dole, M. Pacini, 2006 .

Effectiveness of buprenorphine in double diagnosed patients . Buprenorphine as psychothropic drug

I. Maremmani, M. Pacini, P. Pani, 2006 .

Say “Yes” to Methadone and Buprenorphine in Russian Federation

I. Maremmani, M. Parrino, M. Pacini, 2006 .

Towards a psychopathology specific to Substance Use Disorder: Should emotional responses to life events be included?

G. Perugi, I. Maremmani, C. Conversano, 2018, Comprehensive psychiatry.

Cocaine Abuse in 448 Alcoholics: Evidence for a Bipolar Connection

I. Maremmani, M. Pacini, M. Vitali, 2010 .

Addiction and the Bipolar Spectrum: Dual Diagnosis With a Common Substrate?

G. Perugi, I. Maremmani, H. Akiskal, 2004 .

Opposed effects of hyperthymic and cyclothymic temperament in substance use disorder (heroin- or alcohol-dependent patients).

G. Perugi, I. Maremmani, A. G. Maremmani, 2017, Journal of affective disorders.

Methadone doses and psychopathological symptoms during methadone maintenance.

I. Maremmani, P. Castrogiovanni, O. Zolesi, 1993, Journal of psychoactive drugs.

Impairment of work and leisure in depressed outpatients. A preliminary communication.

H. Akiskal, G. Perugi, I. Maremmani, 1986, Journal of affective disorders.

Substance abuse and psychosis. The strange case of opioids.

I. Maremmani, L. Dell’Osso, L. Rovai, 2014, European review for medical and pharmacological sciences.

Mood Disorders in Heroin Dependence and Clinical Differences Between Heroin Addicts with and without Mood Disorders

I. Maremmani, O. Zolesi, L. Daini, 1995 .

Supervised daily consumption, contingent take-home incentive and non-contingent take-home in methadone maintenance

M. Amore, I. Maremmani, M. L. Gerra, 2011, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

The effectiveness of the combination fluoxetine-naltrexone in bulimia nervosa

I. Maremmani, J. Deltito, P. Castrogiovanni, 1996, European Psychiatry.

Psychopathological symptoms in detoxified and non-detoxified heroindependent patients entering residential treatment

L. Amato, M. Davoli, I. Maremmani, 2015 .

Methadone Dose and Retention During Treatment of Heroin Addicts with Axis I Psychiatric Comorbidity

I. Maremmani, O. Zolesi, M. Aglietti, 2000, Journal of addictive diseases.

The newer Opioid Agonist Treatment with lower substitutive opiate doses is associated with better toxicology outcome than the older Harm Reduction Treatment

I. Maremmani, A. Conca, J. Bizzarri, 2016, Annals of General Psychiatry.

Use of Street Methadone in Italian Heroin Addicts Presenting for Opioid Agonist Treatment

D. Popovic, G. Perugi, I. Maremmani, 2009, Journal of addictive diseases.

The Impact of Misuse and Diversion of Opioid Substitution Treatment Medicines: Evidence Review and Expert Consensus

P. Krajči, C. Roncero, I. Maremmani, 2015, European Addiction Research.

Access to treatment with controlled medicines rationale and recommendations for neutral, precise, and respectful language.

L. Radbruch, I. Maremmani, J. F. Kelly, 2017, Public health.

Post-marketing and clinical safety experience with sodium oxybate for the treatment of alcohol withdrawal syndrome and maintenance of abstinence in alcohol-dependent subjects

I. Maremmani, G. Addolorato, O. Lesch, 2019, Expert opinion on drug safety.

Aggressive Behaviour and Hostility in Depression: Clinical Aspects

I. Maremmani, P. Castrogiovanni, A. D. Muro, 1993 .

Discordance of self ratings versus observer ratings in the improvement of depression: role of locus of control and aggressive behavior.

I. Maremmani, J. Deltito, P. Castrogiovanni, 1989, Comprehensive psychiatry.

Long-Term γ-Hydroxybutyric Acid (GHB) and Disulfiram Combination Therapy in GHB Treatment-Resistant Chronic Alcoholics

I. Maremmani, L. Dell’Osso, A. G. Maremmani, 2011, International journal of environmental research and public health.

Novel strategies to treat alcohol dependence with sodium oxybate according to clinical practice.

I. Maremmani, G. Addolorato, A. Mirijello, 2015, European review for medical and pharmacological sciences.

Addictive and other mental disorders: a call for a standardized definition of dual disorders

I. Maremmani, L. Sher, M. Torrens, 2022, Translational Psychiatry.

Sodium Oxybate as Off-label Treatment for Anxiety Disorder: Successful Outcome in a Low-energy Anxious Resistant Patient

I. Maremmani, L. Dell’Osso, A. G. Maremmani, 2015 .

Psychiatric Symptoms in Patients with Cerebral Endometriosis: A Case Report and Literature Review

G. Perugi, I. Maremmani, L. Lattanzi, 2022, Journal of clinical medicine.

Panic disorder and substance use: clinical significance and psychopathological dynamics

D. Popovic, G. Perugi, I. Maremmani, 2008 .

Buprenorphine: a controlled clinical trial in the treatment of opioid dependence.

G. Gessa, I. Maremmani, P. Pani, 2000, Drug and alcohol dependence.

Is unipolar mania a distinct subtype?

J. Angst, G. Perugi, I. Maremmani, 2007, Comprehensive psychiatry.

The contrasting influence of depressive and hyperthymic temperaments on psychometrically derived manic subtypes

H. Akiskal, G. Perugi, I. Maremmani, 2001, Psychiatry Research.

Psychiatric Aspects of Obesity: A Narrative Review of Pathophysiology and Psychopathology

F. Santini, G. Perugi, I. Maremmani, 2020, Journal of clinical medicine.

Biological correlates of personality: considerations on the possible usefulness of central nervous system peripheral markers

I. Maremmani, D. Marazziti, P. Castrogiovanni, 1993, European Psychiatry.

Emotivity, personality, and task-dependent EEG asymmetry

Enrica Bonanni, Luigi Murri, L. Murri, 1992, Physiology & Behavior.

Risky use and misuse of alcohol and cigarettes in psychiatric inpatients: a screening questionnaire study.

I. Maremmani, A. Conca, J. Bizzarri, 2016, Comprehensive psychiatry.

Anticonvulsants for alcohol dependence.

I. Maremmani, M. Pacini, P. Pani, 2014, The Cochrane database of systematic reviews.

Drug Addiction and Related Clinical Problems

I. Maremmani, A. Tagliamonte, 2003, Springer Vienna.

Methadone Maintenance: A Medical Approach to Heroin Addiction

I. Maremmani, A. Tagliamonte, D. Meloni, 1991 .

Is the Bipolar Spectrum the Psychopathological Substrate of Suicidality in Heroin Addicts?

H. Akiskal, G. Perugi, I. Maremmani, 2007, Psychopathology.

Clinical presentations of substance abuse in bipolar heroin addicts at time of treatment entry

H. Akiskal, I. Maremmani, J. Deltito, 2012, Annals of General Psychiatry.

Recommendations for buprenorphine and methadone therapy in opioid use disorder: a European consensus

J. Bobes, I. Maremmani, A. Benyamina, 2017, Expert opinion on pharmacotherapy.

Substance use and quality of life over 12 months among buprenorphine maintenance-treated and methadone maintenance-treated heroin-addicted patients.

G. Perugi, I. Maremmani, M. Pacini, 2007, Journal of substance abuse treatment.

Research priorities to achieve universal access to hepatitis C prevention, management and direct-acting antiviral treatment among people who inject drugs.

J. Lazarus, M. Hellard, G. Dore, 2017, The International journal on drug policy.

The Importance of a Multi-Disciplinary Approach to the Endometriotic Patients: The Relationship between Endometriosis and Psychic Vulnerability

I. Maremmani, D. Marazziti, E. Papaleo, 2021, Journal of clinical medicine.

C. Roncero, I. Maremmani, H. Alho, 2019, The International journal on drug policy.

Adult-Attention Deficit Hyperactive Disorder Symptoms Seem Not to Influence the Outcome of an Enhanced Agonist Opioid Treatment: A 30-Year Follow-Up

M. Miccoli, G. Perugi, I. Maremmani, 2021, International journal of environmental research and public health.

Symptomatological Variants and Related Clinical Features in Adult Attention Deficit Hyperactive Disorder

M. Scarselli, G. Perugi, I. Maremmani, 2021, International journal of environmental research and public health.

QTc interval screening for cardiac risk in methadone treatment of opioid dependence.

I. Maremmani, M. Pacini, P. Pani, 2013, The Cochrane database of systematic reviews.

Symptomatological Features of Patients with and without Ecstasy Use during Their First Psychotic Episode

I. Maremmani, J. Deltito, L. Dell’Osso, 2012, International journal of environmental research and public health.

Dual Diagnosis and Chronology of Illness in Treatment-Seeking Italian Patients Dependent on Heroin

D. Popovic, G. Perugi, I. Maremmani, 2011, Journal of addictive diseases.

Diagnostic and Symptomatological Features in Chronic Psychotic Patients According to Cannabis Use Status

G. Perugi, M. Lovrečič, I. Maremmani, 2004, Journal of psychoactive drugs.

Alcohol abuse in heroin addicts: An unfolding metabolic destiny.

I. Maremmani, M. Pacini, M. L. Attilia, 2005 .

International Advisory Board

G. Perugi, I. Maremmani, L. Finnegan, 2010 .

Efficacy and safety of sodium oxybate in alcohol‐dependent patients with a very high drinking risk level

D. Nutt, K. Mann, R. Spanagel, 2018, Addiction biology.

Toward a unitary perspective on the bipolar spectrum and substance abuse: opiate addiction as a paradigm.

H. Akiskal, G. Perugi, I. Maremmani, 2006, Journal of affective disorders.

The semi-structured affective temperament interview (TEMPS-I). Reliability and psychometric properties in 1010 14-26-year old students.

H. Akiskal, I. Maremmani, G. Placidi, 1998, Journal of affective disorders.

The relationship of Kraepelian affective temperaments (as measured by TEMPS-I) to the tridimensional personality questionnaire (TPQ).

H. Akiskal, G. Perugi, I. Maremmani, 2005, Journal of affective disorders.

Affective temperament traits measured by TEMPS-I and emotional-behavioral problems in clinically-well children, adolescents, and young adults.

H. Akiskal, G. Perugi, I. Maremmani, 2005, Journal of affective disorders.

A prospective study of stability and change over 2 years of affective temperaments in 14-18 year-old Italian high school students.

H. Akiskal, I. Maremmani, G. Placidi, 1998, Journal of affective disorders.

Delineating the psychic structure of substance abuse and addictions: should anxiety, mood and impulse-control dysregulation be included?

Pedro Parraguez Ruiz, H. Akiskal, G. Gessa, 2010, Journal of affective disorders.

Natural History of Addiction in Psychotic Heroin-addicted Patients at Their First Agonist Opioid Treatment

I. Maremmani, L. Dell’Osso, A. G. Maremmani, 2013 .

Can High Altitude Exacerbate a Remittent Alcohol Use Disorder in a Patient With a History of Panic Attacks?

I. Maremmani, B. Pacciardi, M. Maiello, 2020 .

The influence of affective temperaments and psychopathological traits on the definition of bipolar disorder subtypes: a study on bipolar I Italian national sample.

H. Akiskal, G. Perugi, I. Maremmani, 2012, Journal of affective disorders.

Long-term Usefulness of Cabergoline to Patients in Refraining From Cocaine Use After Detoxification

I. Maremmani, L. Dell’Osso, A. G. Maremmani, 2012 .

Delineating the Psychic Structure of Substance Use and Addictions, from Neurobiology to Clinical Implications: Ten Years Later

G. Gessa, I. Maremmani, A. G. Maremmani, 2020, Journal of clinical medicine.

The long-term outcome of patients with heroin use disorder/dual disorder (chronic psychosis) after admission to enhanced methadone maintenance

G. Perugi, I. Maremmani, A. G. Maremmani, 2018, Annals of General Psychiatry.

Toward the Identification of a Specific Psychopathology of Substance Use Disorders

I. Maremmani, A. G. Maremmani, L. Rovai, 2017, Front. Psychiatry.

Differentiating Between the Course of Illness in Bipolar 1 and Chronic-Psychotic Heroin-Dependent Patients at Their First Agonist Opioid Treatment

I. Maremmani, L. Dell’Osso, A. G. Maremmani, 2015, Journal of addictive diseases.

Psychopathological symptoms of patients with heroin addiction entering opioid agonist or therapeutic community treatment

L. Amato, M. Davoli, I. Maremmani, 2014, Annals of General Psychiatry.

Do methadone and buprenorphine have the same impact on psychopathological symptoms of heroin addicts?

I. Maremmani, L. Dell’Osso, A. G. Maremmani, 2011, Annals of general psychiatry.

Subtyping patients with heroin addiction at treatment entry: factor derived from the Self-Report Symptom Inventory (SCL-90)

G. Perugi, I. Maremmani, G. Gerra, 2010, Annals of general psychiatry.

Sexual Dysfunction in Men Receiving Methadone Maintenance Treatment: Clinical History and Psychobiological Correlates

I. Maremmani, G. Gerra, C. Donnini, 2015, European Addiction Research.

Idee sbagliate ed esperienze allucinatorie in ultra-trailer, corridori d’alta quota

I. Maremmani, L. Pratali, M. Maiello, 2020 .

The extent of misuse and diversion of medication for agonist opioid treatment: A review and expert opinions

P. Krajči, C. Roncero, I. Maremmani, 2015 .

Substance (ab)use during methadone and naltrexone treatment: Interest of adequate methadone dosage

I. Maremmani, A. Sbrana, A. Tagliamonte, 2002 .

Methadone dosages and therapeutic compliance during a methadone maintenance program.

I. Maremmani, P. Castrogiovanni, O. Zolesi, 1994, Drug and alcohol dependence.

Non-medical Use of Prescription Gabapentinoids (Gabapentin and Pregabalin) in Five European Countries

P. Dargan, M. Farré, I. Maremmani, 2021, Frontiers in Psychiatry.

Effect of Psychiatric Severity on the Outcome of Methadone Maintenance Treatment

I. Maremmani, L. Dell’Osso, M. Pacini, 2010, European Addiction Research.

Gender Differences in the Relationship between Maladaptive Behaviors and Post-Traumatic Stress Disorder. A Study on 900 L’ Aquila 2009 Earthquake Survivors

Alessandro Rossi, P. Stratta, A. Rossi, 2013, Front. Psychiatry.

Challenges and Opportunities for the Use of Medications to Treat Opioid Addiction in the United States and Other Nations of the World

I. Maremmani, M. Parrino, A. G. Maremmani, 2015, Journal of addictive diseases.

Long-Term Outcomes of Treatment-Resistant Heroin Addicts with and without DSM-IV Axis 1 Psychiatric Comorbidity (Dual Diagnosis)

G. Perugi, I. Maremmani, G. Gerra, 2008, European Addiction Research.

Addressing misuse and diversion of opioid substitution medication: guidance based on systematic evidence review and real-world experience.

P. Krajči, C. Roncero, I. Maremmani, 2016, Journal of public health.

Re: Letter to the editor of public health in response to 'Access to treatment with controlled medicines rationale and recommendations for neutral, respectful, and precise language'.

L. Radbruch, I. Maremmani, J. F. Kelly, 2018, Public health.

Trends of Hospitalization for Acute Alcohol Intoxication in Slovenian Children and Adolescents with and without Dual Disorder. Implications for a Correct Intervention

M. Lovrečič, I. Maremmani, M. Rok Simon, 2020, Journal of clinical medicine.

Does Cannabis, Cocaine and Alcohol Use Impact Differently on Adult Attention Deficit/Hyperactivity Disorder Clinical Picture?

G. Perugi, I. Maremmani, Marco Carli, 2021, Journal of clinical medicine.

Association between gene variants and response to buprenorphine maintenance treatment

I. Maremmani, G. Gerra, C. Donnini, 2014, Psychiatry Research.

Long-Acting Opioid-Agonists in the Treatment of Heroin Addiction: Why Should We Call Them “Substitution”?

I. Maremmani, J. Tomás-Rosselló, A. Busse, 2009, Substance use & misuse.

Further Evidence of a Specific Psychopathology of Addiction. Differentiation from Other Psychiatric Psychopathological Dimensions (Such as Obesity)

G. Perugi, I. Maremmani, L. Cerniglia, 2017, International journal of environmental research and public health.

Can a Low Dosage of Aripiprazole Modify Incentive Salience in Naive Bipolar Patients Who Gamble?

I. Maremmani, M. G. Carbone, Giovanni Pagni, 2019, Addictive Disorders & Their Treatment.

Affective temperaments in heroin addiction.

H. Akiskal, D. Popovic, G. Perugi, 2009, Journal of affective disorders.

Affective temperaments in alcoholic patients.

I. Maremmani, M. Pacini, M. Vitali, 2009, Alcohol.

Nalmefene in Alcohol Use Disorder Subjects with Psychiatric Comorbidity: A Naturalistic Study

G. Martinotti, I. Maremmani, M. Di Giannantonio, 2017, Advances in Therapy.

Towards a unitary perspective between post-traumatic stress disorder and substance use disorder. Heroin use disorder as case study.

Sara Bertoni, Liliana Dell'Osso, I. Maremmani, 2014, Comprehensive psychiatry.

Nalmefene: clinical and real world evidence in the treatment of alcohol dependence

I. Maremmani, S. Presta, L. Janiri, 2014 .

Sodium Oxybate for Alcohol Dependence: A Network Meta-Regression Analysis Considering Population Severity at Baseline and Treatment Duration

W. van den Brink, D. Nutt, J. Rehm, 2023, Alcohol and alcoholism.

Negative dimension in psychiatry. Amotivational syndrome as a paradigm of negative symptoms in substance abuse.

I. Maremmani, L. Dell’Osso, A. G. Maremmani, 2013, Rivista di psichiatria.

Protracted Hiccups Induced by Aripiprazole and Regressed after Administration of Gabapentin

I. Maremmani, D. Marazziti, M. G. Carbone, 2021, Case reports in psychiatry.

Are "social drugs" (tobacco, coffee and chocolate) related to the bipolar spectrum?

L. Pani, H. Akiskal, G. Muscettola, 2011, Journal of affective disorders.

Six-Month Outcome in Bipolar Spectrum Alcoholics Treated with Acamprosate after Detoxification: A Retrospective Study

I. Maremmani, L. Dell’Osso, A. G. Maremmani, 2014, International journal of environmental research and public health.

Do Akiskal & Mallya's affective temperaments belong to the domain of pathology or to that of normality?

H. Akiskal, I. Maremmani, L. Dell’Osso, 2013, European review for medical and pharmacological sciences.

Alcohol abuse in social phobic patients: is there a bipolar connection?

H. Akiskal, G. Perugi, I. Maremmani, 2002, Journal of affective disorders.

[Psycho(patho)logy of "addiction." Interpretative hypothesis].

I. Maremmani, M. Pacini, Stefania Canoniero, 2002, Annali dell'Istituto superiore di sanita.

Pharmacotherapeutic strategies for the treatment of attention-deficit hyperactivity (ADHD) disorder with comorbid substance-use disorder (SUD)

G. Perugi, I. Maremmani, G. Sani, 2018, Expert opinion on pharmacotherapy.

Does obesity predict bipolarity in major depressive patients?

G. Perugi, I. Maremmani, C. Toni, 2014, Journal of affective disorders.

Is Trazodone Contramid Useful in Inducing Patients to Refrain From Using Cocaine After Detoxification, so Avoiding Early Relapse? A Case Series

M. Scarselli, I. Maremmani, A. G. Maremmani, 2019, Addictive Disorders & Their Treatment.

Psychobiology of Addictions

I. Maremmani, K. Fountoulakis, M. Pacini, 2019, Psychobiology of Behaviour.

Influence of Substance Use Disorder on Treatment Retention of Adult-Attention-Deficit/Hyperactive Disorder Patients. A 5-Year Follow-Up Study

M. Scarselli, G. Perugi, I. Maremmani, 2021, Journal of clinical medicine.

Naltrexone-induced panic attacks.

I. Maremmani, F. Fornai, G. Marini, 1998, The American journal of psychiatry.

Could Temperamental Features Modulate Participation in Clinical Trials?

G. Perugi, I. Maremmani, G. Tognoni, 2023, Journal of clinical medicine.

Aggressive Behavior and Substance Use Disorder: The Heroin Use Disorder as a Case Study

M. T. Avella, I. Maremmani, A. G. Maremmani, 2020 .

The mental status of 1090 heroin addicts at entry into treatment: should depression be considered a 'dual diagnosis'?

H. Akiskal, G. Perugi, I. Maremmani, 2007, Annals of general psychiatry.

Improvement in the quality of live in heroin addicts: Differences between methadone and buprenorphine treatment.

D. Popovic, G. Perugi, I. Maremmani, 2008 .

Psychic Structure of Opioid Addiction: Impact of Lifetime Psychiatric Problems on SCL-90-based Psychopathologic Dimensions in Heroin-dependent Patients

L. Amato, M. Davoli, I. Maremmani, 2016 .

Bipolar Spectrum disorders in Parkinson’s disease: a systematic evaluation

U. Bonuccelli, G. Perugi, I. Maremmani, 2020, CNS Spectrums.

Characteristics of Stress Sensitivity in Heroin Use Disorder Patients during Their Opioid Agonist Treatment

M. Miccoli, I. Maremmani, A. G. Maremmani, 2023, International journal of environmental research and public health.

Discriminative Hypomania Checklist-32 Factors in Unipolar and Bipolar Major Depressive Patients

L. Pani, G. Muscettola, F. Parazzini, 2012, Psychopathology.

Differential Substance Abuse Patterns Distribute According To Gender In Heroin Addicts

I. Maremmani, J. Deltito, F. Golia, 2010, Journal of psychoactive drugs.

Relationships between panic disorder and separation anxiety with school phobia.

G. Perugi, I. Maremmani, J. Deltito, 1988, Comprehensive psychiatry.

Patterns of Management of Patients With Dual Disorder (Psychosis) in Italy: A Survey of Psychiatrists and Other Physicians Focusing on Clinical Practice

G. Martinotti, I. Maremmani, M. Clerici, 2018, Front. Psychiatry.

Remarkable Reduction of Cocaine Use in Dual Disorder (Adult Attention Deficit Hyperactive Disorder/Cocaine Use Disorder) Patients Treated with Medications for ADHD

G. Perugi, I. Maremmani, A. G. Maremmani, 2019, International journal of environmental research and public health.

Psychopathology of addiction: Can the SCL90-based five-dimensional structure differentiate Heroin Use Disorder from a non-substance-related addictive disorder such as Gambling Disorder?

G. Perugi, I. Maremmani, A. G. Maremmani, 2018, Annals of General Psychiatry.

Platelet monoaminooxidase activity and behavioural characteristics in humans.

I. Maremmani, D. Marazziti, P. Bongioanni, 1990, Neuropsychobiology.

Are we ready to treat hepatitis C virus in individuals with opioid use disorder: assessment of readiness in European countries on the basis of an expert-generated model

P. Krajči, C. Roncero, I. Maremmani, 2017, European journal of gastroenterology & hepatology.

Is Aripiprazole Useful to Refrain From Cocaine Use After Detoxification (Avoiding Relapses)?

I. Maremmani, G. Cassano, A. Benedetti, 2009 .

The Conceptual Framework of Dual Disorders and Its Flaws

I. Maremmani, A. G. Maremmani, M. Pacini, 2020, Journal of Clinical Medicine.

The long-term outcomes of heroin dependent-treatment-resistant patients with bipolar 1 comorbidity after admission to enhanced methadone maintenance.

H. Akiskal, I. Maremmani, L. Dell’Osso, 2013, Journal of affective disorders.

Erratum to: Agonist Opioid Treatment as historical comprehensive treatment (‘Dole & Nyswander’ methodology) is associated with better toxicology outcome than Harm Reduction Treatment

I. Maremmani, A. Conca, J. Bizzarri, 2017, Annals of General Psychiatry.

Buprenorphine dosing choices in specific populations: review of expert opinion

P. Krajči, C. Roncero, I. Maremmani, 2016, Expert opinion on pharmacotherapy.

Pattern of cocaine consumption in a sample of italian alcoholics

I. Maremmani, M. Pacini, M. Vitali, 2011 .

Intentional self-poisoning versus other methods of suicide in illicit drug users, according to gender

M. Lovrečič, I. Maremmani, A. G. Maremmani, 2013 .

Psycho-Social and Psychopathological Features as Predictors of Response to Long Term and High Dosages Methadone Treatment

I. Maremmani, P. Castrogiovanni, O. Zolesi, 1991 .

The Development of Temperament Evaluation of Memphis, Pisa, Paris, and San Diego - Auto-questionnaire for Adolescents (A-TEMPS-A) in a Serbian Sample.

H. Akiskal, D. Popovic, I. Maremmani, 2019, Psychiatria Danubina.

Guidelines in the treatment of opiate addiction: a review and recommendation

I. Maremmani, M. Torrens, R. Ali, 2014 .

Challenges of Treating ADHD with Comorbid Substance Use Disorder: Considerations for the Clinician

G. Perugi, I. Maremmani, G. E. Brancati, 2023, Journal of clinical medicine.

Psychomotor Symptoms in Chronic Cocaine Users: An Interpretative Model

I. Maremmani, C. Callegari, M. G. Carbone, 2022, International journal of environmental research and public health.

Prevalence and Clinical Correlates of Comorbid Anxiety and Panic Disorders in Patients with Parkinson’s Disease

U. Bonuccelli, G. Perugi, I. Maremmani, 2021, Journal of clinical medicine.

The promise of Opioid Receptor Antagonist drugs in the treat- ment of neuropsychiatric disorders

I. Maremmani, J. Deltito, 2001 .

Consensus and Controversies Between Pain and Addiction Experts on the Prevention, Diagnosis, and Management of Prescription Opioid Use Disorder.

R. Sittl, D. Bouhassira, I. Maremmani, 2019, Journal of addiction medicine.

Concurrent Abuse of Cannabis Is Associated with a Shorter Duration of Hospitalization in Treatment-Resistant Psychotic Bipolar Inpatients Treated with Clozapine

G. Perugi, I. Maremmani, J. Deltito, 2006 .

Prevalence and diagnostic distribution of medically unexplained painful somatic symptoms across 571 major depressed outpatients

L. Pani, G. Muscettola, F. Parazzini, 2011, Neuropsychiatric disease and treatment.

Treatment Approaches for Patients With Opioid Use Disorder and Chronic Noncancer Pain: a Literature Review

I. Maremmani, Bethany Ketchen, Pamela Eilender, 2016 .

Use of fluoxetine in heroin addiction

I. Maremmani, P. Castrogiovanni, O. Zolesi, 1992, British Journal of Psychiatry.

Exploring the Role of Caffeine Use in Adult-ADHD Symptom Severity of US Army Soldiers

P. Gehrman, G. Perugi, I. Maremmani, 2020, Journal of clinical medicine.

The mental status of 1090 heroin addicts at entry into treatment: should depression be considered a 'dual diagnosis'?

H. Akiskal, G. Perugi, I. Maremmani, 2007 .

The prevention of analgesic opioids abuse: expert opinion.

R. C. Gatti, A. Mugelli, I. Maremmani, 2015, European review for medical and pharmacological sciences.

TEMPS-A[P] temperament profile related to professional choice. Differences between applicants to become a cadet officer in the Italian Air Force or Navy.

H. Akiskal, I. Maremmani, L. Dell’Osso, 2013, Journal of Affective Disorders.

Temperamental traits of women applying for a type of job that has been characterized historically by male identity: the military career as case study.

H. Akiskal, G. Perugi, I. Maremmani, 2011, Journal of affective disorders.

Temperamental traits and results of psychoaptitude tests in applicants to become a cadet officer in the Italian Navy.

I. Maremmani, L. Dell’Osso, A. G. Maremmani, 2013, Journal of affective disorders.

HEROIN ADDICTION AND RELATED CLINICAL PROBLEMS

M. Krausz, M. Farrell, C. O'brien, 2002 .

Research priorities to achieve universal access to hepatitis C prevention, management and direct-acting antiviral treatment among people who inject drugs.

J. Lazarus, M. Hellard, G. Dore, 2017, The International journal on drug policy.

Long-Acting Buprenorphine Formulations as a New Strategy for the Treatment of Opioid Use Disorder

A. Mugelli, I. Maremmani, M. Torrens, 2023, Journal of clinical medicine.

Platelet serotonergic markers and aggressive behaviour in healthy subjects.

I. Maremmani, D. Marazziti, P. Castrogiovanni, 1994, Neuropsychobiology.

The Development of Temperament Evaluation of Memphis, Pisa, Paris, and San Diego - Auto-questionnaire for Adolescents (A-TEMPS-A) in a Serbian Sample.

H. Akiskal, D. Popovic, I. Maremmani, 2019, Psychiatria Danubina.

Workshop of the European Collaborating Centres in Addiction Studies (ECCAS)

I. Maremmani, A. Tagliamonte, 1995 .

EUROPEAN OPIATE ADDICTION TREATMENT ASSOCIATION

G. Perugi, M. Lovrečič, I. Maremmani, 2009 .

Long-Term Outcomes of Treatment-Resistant Heroin Addicts with and without DSM-IV Axis 1 Psychiatric Comorbidity (Dual Diagnosis)

G. Perugi, I. Maremmani, G. Gerra, 2008, European Addiction Research.

Socio-cultural factors affecting drug addiction treatment in Italy (fear of treatment).

I. Maremmani, P. Castrogiovanni, M. Cirillo, 1990, Drug and alcohol dependence.

Is the Bipolar Spectrum the Psychopathological Substrate of Suicidality in Heroin Addicts?

H. Akiskal, G. Perugi, I. Maremmani, 2007, Psychopathology.

DAH-RS: Drug Addiction History Rating Scale

I. Maremmani, P. Castrogiovanni, 1989 .

Towards a unitary perspective between post-traumatic stress disorder and substance use disorder. Heroin use disorder as case study.

I. Maremmani, S. Bertoni, L. Dell’Osso, 2014, Comprehensive psychiatry.

Pseudodementia in Patients with Unipolar and Bipolar Disorders: A Case Series and Literature Review

I. Maremmani, G. E. Brancati, Francesco Weiss, 2024, Journal of clinical medicine.

Mild Behavioral Impairment in Psychogeriatric Patients: Clinical Features and Psychopathology Severity

G. Perugi, I. Maremmani, F. Baldacci, 2023, Journal of clinical medicine.

Heroin addiction history, psychopathology and stress sensitivity in a sample of migrants to Italy

I. Maremmani, M. G. Carbone, Marina Ricci, 2024, Heroin Addiction and Related Clinical Problems.